Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-24 @ 6:42 PM
NCT ID:
NCT06696157
Eligibility Criteria:
Inclusion Criteria:
* Age 18+ (inclusive)
* Meets diagnostic criteria for OUD
* Currently seeking inpatient treatment at Maryland Treatment Centers program
* English speaking
* Willing and able to provide informed consent
* Able to obtain MOUD through insurance.
Exclusion Criteria:
* Having been prescribed and taken a maintenance dose of sublingual buprenorphine or methadone within 14 days of entering the current inpatient treatment episode
* received a dose of XR-buprenorphine or XR-naltrexone within 45 days of entering the current inpatient treatment episode.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06696157
Study Brief:
Protocol Section:
NCT06696157